Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 0.67 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.67 |
| ▸ | CA12 | O43570 | 10/20 | 0.58 |
| ▸ | CA9 | Q16790 | 10/20 | 0.58 |
| ▸ | PTGS2 | P35354 | 8/20 | 0.57 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.57 |
| ▸ | CA1 | P00915 | 4/20 | 0.56 |
| ▸ | CA2 | P00918 | 4/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9048810 | 0.86 | FAAH (0.63) | FAAHKCNH2CA12CA9PTGS2 | |
| SCHEMBL9048316 | 0.85 | FAAH (0.61) | FAAHKCNH2CA12CA9PTGS2 | |
| SCHEMBL9048111 | 0.84 | FAAH (0.60) | FAAHKCNH2CA12CA9PTGS2 | |
| SCHEMBL9048763 | 0.84 | FAAH (0.60) | FAAHKCNH2CA12CA9PTGS2 | |
| SCHEMBL9049345 | 0.84 | FAAH (0.60) | FAAHKCNH2CA12CA9PTGS2 | |
| SCHEMBL23928634 | 0.82 | CA12 (0.80) | FAAHKCNH2CA12CA9PTGS2 | |
| SCHEMBL9048098 | 0.82 | FAAH (0.58) | FAAHKCNH2CA12CA9PTGS2 | |
| SCHEMBL9048935 | 0.82 | PTGS2 (0.78) | FAAHKCNH2CA12CA9PTGS2 | |
| SCHEMBL9047123 | 0.82 | CA12 (0.80) | FAAHKCNH2CA12CA9PTGS2 | |
| SCHEMBL9047468 | 0.81 | FAAH (0.57) | FAAHKCNH2CA12CA9PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0731796-A1 | 1,3,5-TRISUBSTITUTED PYRAZOLE COMPOUNDS FOR TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-09-18 | — | — | EP | claimed |
| WO-1995015318-A1 | 1,3,5-TRISUBSTITUTED PYRAZOLE COMPOUNDS FOR TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1995-06-08 | — | — | WO | claimed |
| EP-0731796-A1 | 1,3,5-TRISUBSTITUTED PYRAZOLE COMPOUNDS FOR TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-09-18 | — | — | EP | disclosed |
| WO-1995015318-A1 | 1,3,5-TRISUBSTITUTED PYRAZOLE COMPOUNDS FOR TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1995-06-08 | — | — | WO | disclosed |